Lupus Erythematosus, Systemic
Information
- Disease name
- Lupus Erythematosus, Systemic
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05141201 | Active, not recruiting | SAPHNELO Systemic Lupus Erythematosus Japan Post-Marketing Surveillance (PMS) | December 21, 2021 | November 30, 2025 | |
| NCT05289544 | Active, not recruiting | N/A | Phone-Based Based Walk With Ease Program for Adults With Arthritis | April 1, 2022 | September 29, 2024 |
| NCT05379725 | Active, not recruiting | N/A | Mediterranean vs. High-Fermented-Food Diet Adherence on Inflammation in Lupus | July 22, 2022 | May 4, 2025 |
| NCT02988661 | Active, not recruiting | N/A | Women Empowered to Live With Lupus Study | January 19, 2017 | February 2025 |
| NCT00025818 | Completed | Phase 3 | Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome | May 2001 | March 2003 |
| NCT00036491 | Completed | Phase 1/Phase 2 | Anti-CD20 in Systemic Lupus Erythematosus | January 2001 | January 2006 |
| NCT00065806 | Completed | Phase 3 | Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) | September 2003 | December 2009 |
| NCT00071487 | Completed | Phase 2 | Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE) | October 2003 | June 2006 |
| NCT00076752 | Completed | Phase 2 | Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus | January 30, 2004 | October 15, 2013 |
| NCT00094380 | Completed | Phase 1/Phase 2 | Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077) | September 2004 | January 2006 |
| NCT00125307 | Completed | Phase 4 | Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis | January 2004 | February 2008 |
| NCT00137969 | Completed | Phase 2/Phase 3 | A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus | May 10, 2005 | August 25, 2008 |
| NCT05326841 | Completed | Phase 3 | Effect of Cholecalciferol Supplementation on Disease Activity and Quality of Life of Systemic Lupus Erythematosus Patients . | October 3, 2021 | January 11, 2022 |
| NCT03187743 | Completed | N/A | Personalised Pharmacological Approach to the Tapering of Corticosteroid Doses in Systemic Lupus Patients Treated With Prednisone | April 17, 2018 | April 20, 2022 |
| NCT03248518 | Completed | N/A | Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases | September 5, 2017 | November 2, 2020 |
| NCT00005778 | Completed | Phase 3 | High-Dose Intravenous (IV) Cyclophosphamide Versus Monthly IV Cyclophosphamide | January 2000 | April 2006 |
| NCT00004643 | Completed | Phase 2 | Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus Erythematosus | February 1995 | |
| NCT03504540 | Completed | Comparison of Complement Factors and Genetic Polymorphisms of AMD Between Patients With Systemic Lupus Erythematosus (SLE) With and Without Retinal "Pseudo-drusen-like" Deposits: Case-control Study (PL-AMD) | April 5, 2018 | May 15, 2021 | |
| NCT03142711 | Completed | Validation of a Mobile Phone Based on EPRO Tool in Subjects With Systemic Lupus Erythematosus | August 21, 2017 | July 3, 2018 | |
| NCT03427151 | Completed | Phase 3 | Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus | February 27, 2018 | February 5, 2019 |
| NCT03161483 | Completed | Phase 2 | A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus | August 31, 2017 | August 3, 2021 |
| NCT03312335 | Completed | Phase 2 | Low-dose Interleukin-2 for Treatment of Systemic Lupus Erythematosus | August 8, 2018 | December 23, 2019 |
| NCT00391924 | Completed | Phase 2 | Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome | May 2000 | January 2003 |
| NCT00392951 | Completed | Phase 1/Phase 2 | Sirolimus for Autoimmune Disease of Blood Cells | December 2006 | February 2016 |
| NCT05278663 | Completed | Phase 1/Phase 2 | A Study to Assess the Safety, Tolerability, and Pharmacokinetics of E6742 in Systemic Lupus Erythematosus Participants | April 14, 2022 | September 4, 2023 |
| NCT00563082 | Completed | Analyzing the Association of Gene Variants With Increased Risk of Coronary Heart Disease in Women With Systemic Lupus Erythematosus | May 2000 | August 2007 | |
| NCT00582465 | Completed | Study to Evaluate the Natural History of Osteoporosis in Children and Adolescents With Systemic Lupus Erythematosus | July 21, 1999 | July 9, 2004 | |
| NCT00611663 | Completed | Phase 2/Phase 3 | Safety Study of Two Vaccine Strategies in Patients With Systemic Lupus Erythematosus | May 2008 | April 2016 |
| NCT00624338 | Completed | Phase 2/Phase 3 | Atacicept Phase 2/3 in Generalized Systemic Lupus Erythematosus (APRIL-SLE) | January 2008 | October 2012 |
| NCT00657189 | Completed | Phase 2 | A Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupus | July 2008 | May 2010 |
| NCT00714116 | Completed | Phase 1 | Study Evaluating The SBI-087 In Subjects With Systemic Lupus Erythematosus | March 2009 | September 2012 |
| NCT00774852 | Completed | Phase 2 | Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis | November 2008 | June 2014 |
| NCT01060410 | Completed | Exploration of Genotype Based Personalized Prescription of Cyclophosphamide in Systemic Lupus Erythematosus Treatment | May 2010 | June 2012 | |
| NCT01093911 | Completed | Phase 1 | Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE) | March 2010 | December 2012 |
| NCT04956484 | Completed | Phase 4 | Belimumab In Early Systemic Lupus Erythematosus | September 1, 2021 | April 8, 2022 |
| NCT01327352 | Completed | N/A | Evaluation of the Influence of Food Regimen on Oshadi D Absorption | April 2011 | October 2011 |
| NCT01405196 | Completed | Phase 2 | Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus | December 2011 | March 2014 |
| NCT04925934 | Completed | Phase 2 | Study of VIB7734 for the Treatment of Moderate to Severely Active SLE | June 24, 2021 | June 9, 2023 |
| NCT01582880 | Completed | Phase 1/Phase 2 | Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis | March 2012 | March 2014 |
| NCT01597050 | Completed | Phase 2 | Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions | August 2012 | September 2013 |
| NCT04776161 | Completed | N/A | Medication Adherence Patterns in Rheumatic Diseases: A Behavioral Trial | August 2, 2021 | November 10, 2022 |
| NCT01702740 | Completed | Phase 1 | A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus | March 2007 | October 2009 |
| NCT01753193 | Completed | Phase 2 | An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in Adults | March 28, 2013 | July 18, 2018 |
| NCT01764594 | Completed | Phase 1 | Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus | January 2013 | August 2014 |
| NCT01838694 | Completed | Phase 1/Phase 2 | Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE. | July 2013 | August 2015 |
| NCT01845740 | Completed | Phase 1 | Phase Ib Study of SC Milatuzumab in SLE | January 2007 | June 2009 |
| NCT01923415 | Completed | A Non-drug Study Profiling Cutaneous Lupus | April 2013 | August 2014 | |
| NCT01972568 | Completed | Phase 2 | Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus | December 2013 | September 2016 |
| NCT02034344 | Completed | A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers | October 2013 | May 2015 | |
| NCT04266860 | Completed | N/A | Establishing Clinical Utility of a New Diagnostic Test for Rheumatology Patients | March 1, 2012 | March 1, 2013 |
| NCT04098055 | Completed | N/A | Effect of Insoles in Patients With Systemic Lupus Erythematosus | November 2, 2019 | February 2, 2022 |
| NCT02162992 | Completed | Systemic Lupus Erythematous and Heart Conduction Disorders | April 2014 | April 2018 | |
| NCT02219269 | Completed | A Complex Contraception Registry | June 2014 | June 2015 | |
| NCT02284984 | Completed | Phase 2 | Synergetic B-cell Immodulation in SLE | March 2014 | October 31, 2018 |
| NCT02349061 | Completed | Phase 2 | A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus | October 15, 2015 | March 13, 2019 |
| NCT03933943 | Completed | Phase 1 | A Study of LY3361237 in Participants With Systemic Lupus Erythematosus | May 21, 2019 | February 15, 2021 |
| NCT02437890 | Completed | Phase 2 | A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus | July 2015 | January 2018 |
| NCT02504645 | Completed | Phase 3 | A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus | March 2015 | January 2018 |
| NCT02537028 | Completed | Phase 1 | MSC2364447C Phase 1b in Systemic Lupus Erythematosus | November 30, 2015 | October 4, 2016 |
| NCT02625831 | Completed | Anti-ficolin-3 Autoantibodies in Lupus Nephritis | November 2012 | May 2014 | |
| NCT00005436 | Completed | Lupus Cohort--Thrombotic Events and Coronary Artery Disease | September 1991 | August 1996 | |
| NCT02655640 | Completed | The Impact of Illness Perceptions on Health Related Outcomes in Patients With Lupus and Systemic Sclerosis | October 2015 | March 2017 | |
| NCT03933839 | Completed | N/A | Internet-Based Pain Coping Skills Training for Patients With Lupus | May 20, 2019 | April 22, 2020 |
| NCT02732470 | Completed | N/A | Effect of Qi Gong Training on Quality of Life in Patients With Systemic Lupus Erythematous (LuQi) | April 25, 2016 | October 31, 2018 |
| NCT02799173 | Completed | N/A | Determination of the RANKL/Osteoprotegerin Ratio in Patients With Systemic Lupus Erythematosus. Role in Osteoporosis and Cardiovascular Calcification | April 15, 2011 | July 1, 2015 |
| NCT03896373 | Completed | Role of the Neonatal Fc Receptor for IgG in the Pathophysiology of Lupus | April 17, 2019 | October 18, 2020 | |
| NCT02875691 | Completed | Phase 2 | Effect of Green Tea on Treatment of Lupus | September 2015 | March 2016 |
| NCT03724916 | Completed | Phase 1 | A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE) | November 26, 2018 | November 4, 2021 |
| NCT02922114 | Completed | N/A | Comparison of the Clinical Examination and the Joint Ultrasonography in Lupus Patients | September 2013 | October 2015 |
| NCT02953821 | Completed | Phase 4 | Acthar Gel for Active Systemic Lupus Erythematosus (SLE) | December 16, 2016 | October 25, 2019 |
| NCT03027674 | Completed | Early Phase 1 | Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud | August 2016 | August 2016 |
| NCT03687138 | Completed | Searching for Diagnostic/Prognostic Biomarkers in SLE With Renal Involvement by Proteomic Techniques | June 15, 2018 | February 28, 2022 | |
| NCT03063281 | Completed | Anti-ficolin-2 Autoantibodies in Lupus Nephritis | November 2012 | May 2015 | |
| NCT03098823 | Completed | Phase 4 | A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE | September 12, 2017 | June 15, 2020 |
| NCT03103243 | Completed | N/A | Pilot Study to Investigate Contemplative Intervention in Lupus Patients | April 27, 2017 | June 4, 2018 |
| NCT05506033 | Enrolling by invitation | N/A | Optimization of Glucocorticoid Taper Strategies for SLE-ITP | August 15, 2022 | December 1, 2025 |
| NCT06087523 | Enrolling by invitation | Pulmonary Disease Among Patients With Systemic Lupus Erythematosus | August 15, 2023 | January 1, 2026 | |
| NCT02422875 | Enrolling by invitation | Comparative Autoantibody and Immunologic Cell Marker Study | August 2012 | August 2024 | |
| NCT04736953 | Not yet recruiting | Phase 2 | Sirolimus Treatment Of Patients With SLE | January 1, 2025 | January 1, 2029 |
| NCT06373991 | Not yet recruiting | Phase 1 | A Study to Evaluate the Safety and Efficacy of ATHENA CAR-T in Subjects With Systemic Lupus Erythematosus | July 24, 2024 | April 30, 2027 |
| NCT06445127 | Recruiting | N/A | Evaluation of Patients With Lupus Nephritis Using Kidney MRI (Magnetic Resonance Imaging) | May 7, 2024 | May 17, 2026 |
| NCT02653287 | Recruiting | N/A | Lupus Intervention for Fatigue Trial | May 1, 2019 | December 2024 |
| NCT03473912 | Recruiting | Meir Medical Center Rheumatologic Biobank | April 16, 2018 | November 2037 | |
| NCT03527472 | Recruiting | Phase 2 | Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus | August 23, 2018 | December 2026 |
| NCT03543839 | Recruiting | Phase 4 | Trial of Belimumab in Early Lupus | September 15, 2020 | December 2026 |
| NCT03747159 | Recruiting | Phase 3 | Synergetic B-cell Immunomodulation in SLE - 2nd Study. | October 1, 2018 | September 2025 |
| NCT03917797 | Recruiting | Phase 2 | Mesenchymal Stromal Cells (MSC´s) in Renal Lupus | April 2, 2019 | December 2025 |
| NCT04895241 | Recruiting | Phase 3 | A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus | May 25, 2021 | September 12, 2025 |
| NCT04961567 | Recruiting | Phase 3 | A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus | July 16, 2021 | March 5, 2026 |
| NCT05193591 | Recruiting | Anti-C1s, Anti-HMGB1 and Anti-C1q Autoantibodies in Systemic Lupus Erythematosus (DYSALARM-322) | January 20, 2022 | October 31, 2025 | |
| NCT05261529 | Recruiting | N/A | Effects of an Intervention With EVOO and Physical Activity in Patients With Systemic Lupus Erythematosus | November 3, 2021 | June 30, 2023 |
| NCT05590390 | Recruiting | Osteoporosis and Fragility Fractures Among SLE Patients. (FRAIL Trial) | December 31, 2022 | December 30, 2023 | |
| NCT05607368 | Recruiting | Mast Cells Are Involved in the Mechanism of NPSLE Epilepsy | January 1, 2022 | December 31, 2025 | |
| NCT05636670 | Recruiting | Assessment of Cognitive Function and Gut Microbiota Analysis in Real World Patients With Lupus Cerebrovascular Disease | October 1, 2022 | September 30, 2024 | |
| NCT05648500 | Recruiting | Phase 3 | A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus | December 13, 2022 | May 1, 2027 |
| NCT05672576 | Recruiting | Phase 3 | A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus | June 26, 2023 | May 1, 2027 |
| NCT05693571 | Recruiting | N/A | Engagement in CHildhood-Onset Systemic Lupus | August 2024 | November 2026 |
| NCT05763225 | Recruiting | Validation of Patient E-tool to Measure Systemic Lupus Activity | February 9, 2023 | September 2024 | |
| NCT05845593 | Recruiting | Relationship Between Data Obtained With the LuGENE® Multiparameter Transcriptomics Blood Test and Clinical and Standard Laboratory Features of Patients With SLE (ReLATE) | December 19, 2023 | March 5, 2025 | |
| NCT05863689 | Recruiting | Microvascular Ocular Changes of Systemic Lupus Erythematous | May 10, 2023 | December 2025 | |
| NCT05879718 | Recruiting | Phase 2 | A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms. | July 7, 2023 | November 18, 2026 |
| NCT05899907 | Recruiting | Phase 4 | Efficacy and Safety of Telitacicept in Early SLE | September 1, 2022 | September 1, 2025 |
| NCT05961267 | Recruiting | Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism | July 24, 2023 | July 2024 | |
| NCT05967520 | Recruiting | Phase 2 | JMKX000189 for Moderate to Severe Active Systemic Lupus Erythematosus | September 21, 2023 | December 2025 |
| NCT06015230 | Recruiting | Phase 1/Phase 2 | Clinical Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GR1603 in SLE | March 8, 2022 | October 4, 2028 |
| NCT06166199 | Recruiting | N/A | Effects of High-intensity Interval Training in Patients With Systemic Lupus Erythematosus | November 1, 2022 | December 31, 2026 |
| NCT06316791 | Recruiting | Early Phase 1 | Exploratory Clinical Study of CNCT19 Anti CD19 Cell Therapy in the Treatment of Refractory Autoimmune Diseases | December 14, 2021 | December 13, 2025 |
| NCT00381810 | Terminated | Phase 3 | A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus | June 22, 2006 | February 29, 2012 |
| NCT01127321 | Terminated | Phase 1 | A Safety and Tolerability Study of MEDI-570 in Systemic Lupus Erythematosus | May 2010 | July 2012 |
| NCT02070978 | Terminated | Phase 2 | Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II) | July 29, 2014 | February 9, 2018 |
| NCT00152555 | Terminated | N/A | Physical Therapy for Systemic Lupus Erythematosus (SLE) | March 2003 | March 2007 |
| NCT00368264 | Terminated | Phase 2/Phase 3 | TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL ) | September 2006 | June 2009 |
| NCT02428309 | Terminated | Phase 1 | Autologous Polyclonal Tregs for Lupus | August 27, 2015 | October 3, 2018 |
| NCT05203419 | Terminated | Phase 1 | Multiple Ascending Dose Study of MHS552 in Adults Participants With Systemic Lupus Erythematosus (SLE) | March 15, 2022 | June 4, 2023 |
| NCT00325741 | Terminated | Phase 1 | Allogeneic Blood Stem Cell Transplantation for Patients With Life-Threatening Systemic Lupus Erythematosus | June 2004 | October 2015 |
| NCT02711813 | Terminated | Phase 2 | TAB08 in Patients With Systemic Lupus Erythematosus (SLE), Not Adequately Controlled With Current Treatment | March 2016 | May 2018 |
| NCT03200548 | Terminated | N/A | Acupressure for Fatigue in Systemic Lupus Erythematosus | August 14, 2017 | July 19, 2019 |
| NCT03407482 | Terminated | Phase 2 | An Extension Study of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus | January 9, 2018 | November 20, 2019 |
| NCT02041091 | Terminated | Phase 3 | A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus | January 2014 | November 2015 |
| NCT00113971 | Terminated | Phase 2 | Pharmacokinetics Study of Epratuzumab in Systemic Lupus Erythematosus (SLE) | April 2005 | June 2007 |
| NCT03488654 | Terminated | CMR-Lupus Comprehensive Approach by Cardiovascular Magnetic Resonance Tomography | July 2010 | December 2014 | |
| NCT01257802 | Terminated | Phase 3 | GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic Diseases | May 2011 | November 2015 |
| NCT03517722 | Terminated | Phase 3 | A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus | April 16, 2018 | November 5, 2020 |
| NCT00089804 | Terminated | Phase 3 | Study of LJP 394 in Lupus Patients With History of Renal Disease | October 2004 | February 2009 |
| NCT04449653 | Unknown status | Mobile Study to Measure and Predict Lupus Disease Activity Using Digital Signals | April 28, 2020 | June 1, 2021 | |
| NCT01471301 | Unknown status | Ultrasound Evaluation of Hands in Patients With Systemic Lupus Erythematosus | June 2011 | ||
| NCT00008749 | Unknown status | Role of Altered CD40-Ligand Gene Transcription in Systemic Lupus Erythematosus | |||
| NCT03144063 | Unknown status | Improving the Assessment of SLE Disease Activity | July 11, 2017 | June 2018 | |
| NCT03142412 | Unknown status | Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment Optimization | April 17, 2017 | October 17, 2021 | |
| NCT00420121 | Unknown status | European Society of Cutaneous Lupus Erythematosus (EUSCLE) | January 2007 | December 2019 | |
| NCT03042260 | Unknown status | Phase 4 | Prophylactic Trimethoprim/Sulfamethoxazole to Prevent Severe Infections in Patients With Lupus Erythematous | March 1, 2017 | August 2021 |
| NCT03746197 | Unknown status | N/A | Interactive Digital Technology to Assess and Improve Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus | June 6, 2018 | July 1, 2020 |
| NCT02822989 | Unknown status | N/A | Using the Cholinergic Anti-Inflammatory Pathway to Treat Systemic Lupus Musculoskeletal Pain | November 1, 2017 | November 1, 2020 |
| NCT04032496 | Unknown status | N/A | Contemplation-Based Intervention and Health Outcomes RCT in Lupus Patients | January 2020 | July 2021 |
| NCT04213690 | Unknown status | A Pilot Study to Explore the Role of Gut Flora in Lupus | March 2, 2020 | July 2023 | |
| NCT04361734 | Unknown status | The Role of Lipids in Immune Cell Function in SLE Patients | February 15, 2016 | August 31, 2020 | |
| NCT01852851 | Unknown status | N/A | Employment and Arthritis: Making it Work | June 2013 | June 2023 |
| NCT03771885 | Withdrawn | Phase 1 | BI 705564 in Patients With Systemic Lupus Erythematosus (SLE) | March 16, 2019 | January 7, 2020 |
| NCT01702038 | Withdrawn | Phase 2 | Determining the Responses and Impact of Rituximab-instigated Cell Depletion on T Cells in People With SLE | September 2009 | |
| NCT04060888 | Withdrawn | Phase 3 | A Study of Ustekinumab in Chinese Participants With Active Systemic Lupus Erythematosus | July 14, 2020 | March 31, 2026 |
| NCT02920424 | Withdrawn | Phase 1 | A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-56022473 in Subjects With Systemic Lupus Erythematosus | June 30, 2017 | September 26, 2019 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D008180